Singapore, 10 February 2025 – Life Science Incubator (LSI) celebrated a major milestone today with the official launch of its cutting edge & largest co-working laboratory in Singapore at Elementum, located in JTC’s one-north business park. This launch further strengthens Singapore’s prominence as a premier life sciences hub in Asia Pacific.
The grand opening event was officiated by Guest-of-Honour, Senior Minister of State Low Yen Ling, alongside Altea Investments CIO, John Ratcliffe and Life Science Incubator, Director, Zeïna Henni. The event drew key stakeholders from Singapore’s life sciences ecosystem, including representatives from research institutions, accelerators, and industry leaders.
As Singapore continues to be a preferred destination for biotech, MedTech, and pharmaceutical innovation and the demand for high-quality laboratory space remains high. LSI’s new state of the art, fully-equipped co-working laboratory at Elementum directly addresses the increasing need for high-quality lab space, supporting startups, entrepreneurs, and multinational firms to scale their operations in this key life sciences hub.
“Our mission at LSI is to remove barriers for life sciences startups and innovators by providing the critical infrastructure they need to accelerate breakthroughs,” said Zeïna Henni, Director of LSI. “Singapore’s life sciences sector is entering an exciting phase of growth, and we’re proud to be part of this journey, supporting the next wave of transformative advancements in healthcare and biotechnology.“
Singapore as a Rising Hub for Life Science Innovation
Investor confidence in Singapore’s healthtech and life sciences sector remain strong, with 14 companies raising S$92.4 million in 2024, making it the top destination in Southeast Asia for biotech investment. This commitment is reinforced by significant investments under the Research, Innovation and Enterprise 2025 plan (RIE2025), which has allocated approximately S$28 billion in 2024, to strengthen key sectors including life sciences. Additionally, the country’s world-class regulatory framework and intellectual property protections continue to attract leading biotech and MedTech firms, further cementing the nation’s status as a premier hub for life sciences innovation.
The working laboratory provides a range of flexible lab and office solutions to meet the diverse needs of life science companies. Beyond open lab spaces, Elementum offers larger private suites that can house dedicated tissue culture rooms with highly specified control. Tenants can benefit from a high degree of customisation, with the opportunity to design bespoke wet lab and office space components. With adaptable contract arrangements and full-service support, the space caters to both startups and established enterprises. Moreover, Elementum fosters a vibrant and innovative community, providing opportunities for connectivity and collaboration among its tenants.
“The expansion of LSI at Elementum marks a pivotal step in strengthening Singapore’s position as a leading life sciences hub in the Asia-Pacific. This co-working laboratory will provide the critical space and resources needed for startups, researchers, and global firms to accelerate advancements in biotechnology and medical innovation,” shared John Ratcliffe, CIO, Altea Investments.
Next Steps
With this expansion, LSI has tripled its laboratory space, reinforcing its position as Singapore’s leading independent provider of co-working laboratory solutions. The facility at Elementum will cater to the growing number of startups and international firms looking for agile, high-quality lab spaces in one of the world’s most dynamic life sciences ecosystems.
Looking ahead, LSI is set to expand into the broader APAC region, with Australia as its next key market. Australia presents a highly attractive market with its strong focus on research and development, efficient clinical trial processes, and access to top-tier educational institutions and talent. Leveraging three years of active engagement in the Australian life sciences ecosystem, LSI has built strong relationships with the community, academia, and government agencies. The company is currently in discussions through its established network for the potential launch of its first LSI Australia location later this year.
For more information, visit https://www.lifescienceincubator.com/
About Life Science Incubator
Life Science Incubator (LSI) builds and operates world-class co-working laboratories, providing fully equipped, agile, and reliable lab spaces for BioTech, MedTech, and FoodTech companies to develop and scale. Following the success of our first laboratory at the German Centre in 2021, we have expanded through a strategic collaboration with Ho Bee Land into Elementum, a cutting-edge biomedical hub in one-north, Singapore.
With eight of the world’s top ten pharmaceutical and MedTech firms establishing a significant presence in Singapore, the demand for high-quality, flexible lab spaces continues to grow. LSI is designed to meet this demand, offering startups and established businesses cost-effective, fully serviced lab solutions without the constraints of long leases or high capital expenditure.
Beyond supporting startups, LSI also attracts SMEs and multinational corporations (MNCs) that are expanding into Singapore but are not yet ready to commit to building their own facilities. LSI provides a low-risk entry point, offering state-of-the-art infrastructure alongside access to our network of startups, researchers, and industry leaders. By integrating these companies into our vibrant community, LSI facilitates introductions to potential collaborators, partners, and government agencies—helping them accelerate market entry and scale more efficiently.
LSI works closely with local accelerators, universities, and polytechnics to stimulate entrepreneurship and provide external resources to support spin-offs and new ventures. In doing so, LSI contributes to talent developments in Singapore’s thriving life sciences sector.
About Altea
Altea Investments, a portfolio company of RAVA Partners, Hillhouse Investment’s real assets platform, is a pan-Asian (ex-China) provider of real asset solutions for the life sciences sector. Focused on developing, acquiring, and operating high-quality lab spaces, research facilities, and innovation centers, Altea supports the growth of key life sciences clusters across the APAC region. Through partnerships with universities, research institutions, industry leaders, and governments, Altea helps build the infrastructure needed to advance life sciences research and commercialization. Combining expertise in real assets and life sciences, Altea delivers practical, long-term solutions to drive industry growth.
